Computer-Assisted Selective Optimization of Side-Activities-from Cinalukast to a PPARα Modulator

ChemMedChem. 2019 Jul 17;14(14):1343-1348. doi: 10.1002/cmdc.201900286. Epub 2019 Jun 27.

Abstract

Automated computational analogue design and scoring can speed up hit-to-lead optimization and appears particularly promising in selective optimization of side-activities (SOSA) where possible analogue diversity is confined. Probing this concept, we employed the cysteinyl leukotriene receptor 1 (CysLT1 R) antagonist cinalukast as lead for which we discovered peroxisome proliferator-activated receptor α (PPARα) modulatory activity. We automatically generated a virtual library of close analogues and classified these roughly 8000 compounds for PPARα agonism and CysLT1 R antagonism using automated affinity scoring and machine learning. A computationally preferred analogue for SOSA was synthesized, and in vitro characterization indeed revealed a marked activity shift toward enhanced PPARα activation and diminished CysLT1 R antagonism. Thereby, this prospective application study highlights the potential of automating SOSA.

Keywords: automation; nuclear receptors; peroxisome proliferator-activated receptors; virtual combinatorial library.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Binding Sites
  • Humans
  • Leukotriene Antagonists / chemistry
  • Ligands
  • Molecular Docking Simulation
  • PPAR alpha / agonists*
  • PPAR alpha / chemistry
  • PPAR alpha / metabolism
  • Proof of Concept Study
  • Receptors, Leukotriene / chemistry
  • Small Molecule Libraries / chemistry*
  • Small Molecule Libraries / metabolism
  • Thiazoles / chemistry

Substances

  • Leukotriene Antagonists
  • Ligands
  • PPAR alpha
  • Receptors, Leukotriene
  • Small Molecule Libraries
  • Thiazoles
  • cinalukast
  • leukotriene D4 receptor